LY353381 in Preventing Breast Cancer in Women With Hyperplasia

Completed · Phase 2 · Has a placebo group

Conditions studied: Breast Cancer

In brief

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of LY353381 may be an effective way to prevent the development of breast cancer in women who have hyperplasia. PURPOSE: Randomized phase II trial to study the effectiveness of LY353381 in preventing breast cancer in women who have hyperplasia.

Key facts

Study ID

NCT00005879

Run by

University of Kansas Medical Center

People needed

199

Starts

2000-08-01

Expected to finish

2008-07-01

Last updated by the study team

2017-05-30

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: accepted.

Where it is running

• University of Kansas Medical Center — Kansas City, Kansas, United States
• U.S. Oncology Research, Inc. — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.